STTK

Shattuck Labs (STTK)

About Shattuck Labs (STTK)

Shattuck Labs, Inc. is a clinical-stage biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. It focuses on developing a potential first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.

Details

Daily high

$7.42

Daily low

$7.22

Price at open

$7.30

52 Week High

$8.33

52 Week Low

$0.71

Market cap

647.1M

Dividend yield

0.00%

Volume

894,453

Avg. volume

1.3M

P/E ratio

-11.25

Shattuck Labs News